Pharma Tech Industries Welcomes Darrin Schellin as New CEO

Pharma Tech Industries, a prominent global provider of contract manufacturing and packaging for pharmaceuticals, medical devices, and wellness products, has appointed Darrin T. Schellin as its new CEO. Schellin brings over two decades of experience in the healthcare and pharmaceutical industries, known for his ability to drive operational improvements and spark innovation. His leadership is expected to steer Pharma Tech Industries into its next growth phase, as the company seeks to expand its service offerings and broaden its international footprint.

Schellin has a robust background in executive leadership, with his most recent position being CEO of GBI Bio. There, he played a key role in evolving the company from a clinical phase contract development and manufacturing organization (CDMO) to a comprehensive clinical and commercial biotech CDMO. This achievement highlights his knack for fostering growth and forging strong industry partnerships. His extensive experience makes him a perfect fit for the long-term vision of Pharma Tech Industries.

Tee Noland, Chairman of the Board, said in a statement, "We are thrilled to welcome Darrin to Pharma Tech Industries. His deep understanding of the industry, strategic vision, and operational expertise make him the ideal leader to steer our company into the future."

Schellin mentioned, "I am honoured to join Pharma Tech Industries at such an exciting time in its journey. As I step into this leadership role, I’m inspired by the potential we have to innovate and collaborate in driving advancements that will improve lives.  I look forward to working with our talented team to build on the company's impressive legacy of innovation, quality, and customer focus. Together, we will continue to deliver best-in-class solutions to our partners and customers.”